Darmkrebsfrüherkennung

Darmkrebsfrüherkennung refers to the early detection of colorectal cancer, also known as colon cancer or bowel cancer. This process aims to identify precancerous polyps or early-stage cancers before they cause significant symptoms or spread to other parts of the body. Early detection dramatically increases the chances of successful treatment and survival.

The primary methods for colorectal cancer screening include colonoscopy and stool-based tests. Colonoscopy involves inserting a flexible tube with a camera into the rectum and colon, allowing direct visualization of the lining. Polyps can be removed during this procedure. Stool-based tests, such as the fecal occult blood test (FOBT) or the fecal immunochemical test (FIT), detect microscopic amounts of blood in the stool, which can be an indicator of polyps or cancer. Newer tests, like the fecal DNA test, also look for abnormal DNA from cancer cells in the stool.

Recommendations for screening vary by age, gender, and individual risk factors. Generally, screening is recommended to begin at age 50 for individuals at average risk. Those with a family history of colorectal cancer or inflammatory bowel disease may need to start screening earlier and undergo more frequent testing. The choice of screening method often depends on patient preference, availability, and physician recommendation. Regular participation in recommended screening programs is crucial for maximizing the benefits of early detection.